Use of microcirculatory parameters to evaluate chronic venous insufficiency.

C. E. Virgini-Magalhães,C. Porto,Fabiano F A Fernandes,D. Dorigo,D. Bottino,E. Bouskela

DOI: https://doi.org/10.1016/J.JVS.2005.12.065

IF: 4.86

2006-05-01

Journal of Vascular Surgery

Abstract:

What problem does this paper attempt to address?

New roles for pharmacists in community mental health care: a narrative review

Maria Rubio-Valera,Timothy F Chen,Claire L O'Reilly

DOI: https://doi.org/10.3390/ijerph111010967

2014-10-21

Abstract:Medicines are a major treatment modality for many mental illnesses, and with the growing burden of mental disorders worldwide pharmacists are ideally positioned to play a greater role in supporting people with a mental illness. This narrative review aims to describe the evidence for pharmacist-delivered services in mental health care and address the barriers and facilitators to increasing the uptake of pharmacist services as part of the broader mental health care team. This narrative review is divided into three main sections: (1) the role of the pharmacist in mental health care in multidisciplinary teams and in supporting early detection of mental illness; (2) the pharmacists' role in supporting quality use of medicines in medication review, strategies to improve medication adherence and antipsychotic polypharmacy, and shared decision making; and (3) barriers and facilitators to the implementation of mental health pharmacy services with a focus on organizational culture and mental health stigma. In the first section, the review presents new roles for pharmacists within multidisciplinary teams, such as in case conferencing or collaborative drug therapy management; and new roles that would benefit from increased pharmacist involvement, such as the early detection of mental health conditions, development of care plans and follow up of people with mental health problems. The second section describes the impact of medication review services and other pharmacist-led interventions designed to reduce inappropriate use of psychotropic medicines and improve medication adherence. Other new potential roles discussed include the management of antipsychotic polypharmacy and involvement in patient-centered care. Finally, barriers related to pharmacists' attitudes, stigma and skills in the care of patients with mental health problems and barriers affecting pharmacist-physician collaboration are described, along with strategies to reduce mental health stigma.
Community pharmacists’ views and experiences of delivering in-pharmacy medication reviews for people living with severe and persistent mental illness: a qualitative study

Ricki Ng,Sarira El-Den,Jack C. Collins,Sara S. McMillan,Jie Hu,Amanda J. Wheeler,Claire L. O’Reilly

DOI: https://doi.org/10.1007/s11096-024-01720-2

IF: 2.305

2024-03-29

International Journal of Clinical Pharmacy

Abstract:Abstract Background People living with severe and persistent mental illness (SPMI) often take multiple medications and are at risk of experiencing medication related problems. Medication review services have the potential to reduce inappropriate use of psychotropic medications and improve adherence. However, there is limited research regarding pharmacists’ perspectives when providing such services. Aim To explore community pharmacists’ views and experiences of providing an in-pharmacy medication review (MedsCheck) for people living with SPMI. Method Semi-structured interviews were conducted between November 2021 and May 2022 with community pharmacists participating in the comparator group of the PharMIbridge Randomised Controlled Trial (RCT), which aimed to improve medication adherence and manage physical health concerns for people living with SPMI. Interviews were recorded, transcribed, and analysed using inductive thematic analysis. Results Fifteen semi-structured interviews were conducted with community pharmacists including pharmacy owners, managers and employee pharmacists. Most pharmacist participants who were interviewed (n = 10) were aged under 39 and more than half (n = 8) had 10 or more years of pharmacy experience. Five key themes were identified: 1) Pharmacists’ roles in the management of SPMI in community pharmacy; 2) Mental health education and training; 3) Pharmacy resources; 4) Challenges with interprofessional collaboration and 5) Impact on professional relationships and consumer outcomes. Conclusion Pharmacists are motivated to support people living with SPMI. Mental health training, as well as arrangements regarding pharmacy workflow and appropriate remuneration are needed to enable pharmacists to better support people living with SPMI. Referral pathways should be directly accessible by community pharmacists to assist interprofessional collaboration.

pharmacology & pharmacy
Accelerating analysis for metabolomics, drugs and their metabolites in biological samples using multidimensional gas chromatography.

B. Mitrevski,K. Kouremenos,P. Marriott

DOI: https://doi.org/10.4155/bio.09.28

IF: 2.695

2009-06-11

Bioanalysis

Abstract:Gas chromatography (GC) with mass spectrometry (MS) is one of the great enabling analytical tools available to the chemical and biochemical analyst for the measurement of volatile and semi-volatile compounds. From the analysis result, it is possible to assess progress in chemical reactions, to monitor environmental pollutants in a wide range of soil, water or air samples, to determine if an athlete or horse trainer has contravened doping laws, or if crude oil has migrated through subsurface rock to a reservoir. Each of these scenarios and samples has an associated implementation method for GC-MS. However, few samples and the associated interpretation of data is as complex or important as biochemical sample analysis for trace drugs or metabolites. Improving the analysis in both the GC and MS domains is a continual search for better separation, selectivity and sensitivity. Multidimensional methods are playing important roles in providing quality data to address the needs of analysts.
A roadmap beyond dispensing for educating and training community pharmacists on key mental health competencies: A mixed-methods national study

Hamzah Alzubaidi,Ward Saidawi,Lisa Goldstone,Basema Saddik,Abduelmula R. Abduelkarem,Eman Abu-Gharbieh,Karem H. Alzoubi,Catarina Samorinha

DOI: https://doi.org/10.1016/j.sapharm.2024.03.001

IF: 3.348

2024-03-16

Research in Social and Administrative Pharmacy

Abstract:Background Including pharmacists in collaborative mental healthcare models has yielded positive results. Establishing processes to enhance pharmacists' mental health care capabilities is crucial for addressing the increasing burden and improving access to mental health services. Objectives This study evaluated community pharmacists' mental health competencies and analyzed associated factors using a rigorous international framework. Additionally, it sought to identify pharmacists' training needs and support requirements as the first stop in creating a roadmap for enhancing mental healthcare through community pharmacies. Methods A large-scale national study employing a mixed-methods approach was conducted with community pharmacists in United Arab Emirates. Semi-structured individual interviews and a cross-sectional survey were conducted. Pharmacists' core competencies were assessed using the Core Mental Health Competencies Framework for all Pharmacy Professionals. Generalized linear models were utilized to identify predictors of pharmacists' competency levels. Thematic analysis was used to analyze qualitative data. Results In total 650 community pharmacists completed the survey (93.7% response rate). Eight pharmacists participated in semi-structured interviews. Nearly two-thirds (63.7%) received general communication skills training, while training in motivational interviewing (44.7%), shared decision-making (37.2%), and mental illness stereotyping/stigma (23.9%) were less common. Pharmacists reported lower perceived competence in their relationship with multidisciplinary teams (M = 3.02, SD = 0.89), stigma recognition (M = 3.02, SD = 1.04), and identifying mental health crises and aiding in the person's safety (M = 3.01, SD = 1.05). Poor communication skills (p < 0.001) and working in pharmacies that do not stock psychotropic medications (p = 0.023) were associated with lower perceived competence. Qualitative analysis identified training needs in various domains, including attitudes, values, and beliefs about mental health; relationships with multidisciplinary teams; communication skills; pharmaceutical knowledge; and personal and service development. Conclusions Mental health-related training is needed for community pharmacists. Addressing these needs through an intentional roadmap approach will enable pharmacists to better engage with patients with mental illness and increase access to care.

public, environmental & occupational health
Intrinsic optical transistor action in homeotropically aligned nematic crystal films.

E. Santamato,A. Sasso,R. Bruzzese,Y. Shen

DOI: https://doi.org/10.1080/15421408708084612

IF: 3.6

1986-07-01

Optics Letters

Abstract:We report the observation of intrinsic optical transistor action in a homeotropically aligned nematic liquid-crystal film, resulting from the large nonlinearity associated with the optical Freedericksz transition in the nematic sample. No external feedback is employed.
AntimicrobiALs Peptidoglycan hydrolase enzyme fusions for treating multi-drug resistant pathogens

S. C. Becker,S. Dong,J. Baker,J. Foster-Frey,D. Pritchard

Abstract:
Exploring Youth-Perceived Barriers and Attitudes Towards the Clinical Use of Pharmacogenetic Testing to Optimise Antidepressant Pharmacotherapy

Bradley Roberts,Zahra Cooper,Georgia Landery,Susanne Stanley,Bernadette T Majda,Khan RL Collins,P Anthony Akkari,Sean D Hood,Jennifer Rodger

DOI: https://doi.org/10.1101/2024.08.25.24312539

2024-08-26

Abstract:The field of pharmacogenetics (PGx) is experiencing significant growth, with increasing evidence to support its application in psychiatric care, suggesting its potential to personalise treatment plans, optimise medication efficacy, and reduce adverse drug reactions. However, the perceived utility and practicability of PGx for psychiatric treatment in youth remains underexplored. This study investigated youth-perceived barriers and attitudes towards the implementation of PGx testing to guide antidepressant treatment in primary care. Semi-structured focus groups and interviews were conducted with 17 participants aged between 18 to 24 years. These sessions were recorded and transcribed before thematic analysis was used to identify collective themes. Three key themes were identified, including attitudes towards the medication prescription process, concerns and attitudes towards PGx testing, and perceived barriers to its clinical implementation. Although PGx testing was positively perceived by most participants, all participants shared concerns about PGx testing. Participants voiced concerns about the financial impact of PGx testing, the potential for treatment delays, and the accuracy of PGx testing in guiding antidepressant treatment. Additionally, participants noted that the low awareness and willingness of general practitioners to incorporate PGx testing into routine practice could hinder successful clinical implementation. Prior to the implementation of PGx testing into Australian primary practices, it is essential to acknowledge patient perspectives and ensure that clinical practices remain patient-focused. This study highlights important considerations for integrating PGx testing into antidepressant pharmacotherapy and emphasizes the need for future research to address and mitigate youth-perceived barriers.
Mental Health Simulation Training for Pharmacy workforce in Secondary Care

S Daniel,E Walker,M Hinson-Raven,F Serra,I Salim

DOI: https://doi.org/10.1093/ijpp/riad074.018

2023-11-30

International Journal of Pharmacy Practice

Abstract:Abstract Introduction Simulation involves life-like scenarios followed by reflection within a facilitated debrief and is widely used in healthcare education. The NHS Long Term plan1 and HEE2 reports highlight the need for the pharmacy workforce in different sectors to be confident and competent in providing care for people with mental health illnesses. Similarly, local integrated care services (ICSs) are prioritising parity of esteem and bridging gaps between services through an improved workforce. Aim To increase the pharmacy workforce’s confidence in supporting and caring for patients with mental health illnesses, reduce stigma, and empower staff to provide a safe, effective, and equitable service. Specific objectives were to: become familiar with substance misuse & learning disabilities; improve effective communication (verbal and non-verbal); and build confidence in formulating treatment plans, talking to patients in distress and taking appropriate histories within a mental health context. Methods Participants included medicines management pharmacy technicians (MMPTs) and pharmacists who volunteered from the acute and mental health Trusts within ICS. The training format included pre-reading clinical material, simulation scenarios co-produced with service users, multi-disciplinary team teaching, and debriefs. Ethical approval not required for the evaluation of the training. We collected quantitative and fee-text data via pre- and post-simulation questionnaires (two validated scales and course specific questionnaire). The data were subjected to descriptive statistical analysis and thematic grouping of free-text data with frequency counting. Results The whole group (n=29) showed an increase in empathy and improvement in attitudes towards people with mental health illness from pre to post simulation training. The 15 measures (course specific questionnaire) and the qualitative feedback indicated that the learning objectives were met. 100% of participants either strongly agreed/agreed that the simulation training helped improve their communication skills and found the debrief and service user participation valuable. The qualitative data supported these findings: “...gained confidence in speaking to patients with different forms of mental health conditions and patients who are in distress.” Discussion/Conclusion This project was a pioneer to assess the use of mental health simulation training within secondary care between two different practice settings. Whilst a small-scale study only, the findings showed improved communication and confidence within a mental health context, particularly in talking to patients in distress. The simulation training was well received by participants and supports the use of simulation in our aim of increasing pharmacy workforce confidence in caring for those with mental illness and reducing stigma. In addition to improving clinical knowledge and skills, simulation training can also help improve pharmacy staff perceptions, attitudes, and address stigma and hence contribute towards a high quality patient care service. This project indicates the potential value of training the pharmacy workforce on a wider scale, regardless of sector, in collaboration with MDT and service users. References 1. NHS England. The NHS Long Term Plan [Internet]. NHS England; 2019 [updated 2019 August 21; cited 2023 February 20]. Available from: https://www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term-plan-version-1.2.pdf 2. A.Tyrrell. A Review of Innovative and Extended Roles within Mental Health Pharmacy [Internet]. Health Education England; 2020 [cited 2023 March 2]. Available from: https://www.hee.nhs.uk/sites/default/files/documents/Pharmacy%20Extended%20Roles%20Report.pdf
Exploring Australian pharmacists' views toward reducing the risk of medicines-related harm in aged care residents

Sheraz Ali,Colin M Curtain,Gregory M Peterson,Mohammed S Salahudeen

DOI: https://doi.org/10.1002/prp2.1104

Abstract:Medicines-related harm is common in older people living in residential aged care facilities (RACFs). Pharmacists offering services in the aged care sector may play a key role in reducing medicines-related injury. This study aimed to explore Australian pharmacists' views toward reducing the risk of medicines-related harm in older residents. Qualitative, semi-structured interviews were conducted with 15 Pharmacists across Australia providing services (e.g., through the provision of medication reviews, supplying medications, or being an embedded pharmacist) to RACFs identified via convenience sampling. Data were analyzed by thematic analysis using an inductive approach. Medicines-related harm was thought to occur due to polypharmacy, inappropriate medicines, anticholinergic activity, sedative load, and lack of reconciliation of medicines. Pharmacists reported that strong relationships, education of all stakeholders, and funding for pharmacists were facilitators in reducing medicines-related harm. Pharmacists stated that renal impairment, frailty, staff non-engagement, staff burnout, family pressure, and underfunding were barriers to reducing medicines-related harm. Additionally, the participants suggested pharmacist education, experience, and mentoring improve aged care interactions. Pharmacists believed that the irrational use of medicines increases harm in aged care residents, and medicines-specific (e.g., sedative load) and patient-specific risk factors (e.g., renal impairment) are associated with injuries in residents. To reduce medicines-related harm, the participants highlighted the need for increased funding for pharmacists, improving all stakeholders' awareness about medicines-associated harms through education, and ensuring collaboration between healthcare professionals caring for older residents.
Acquired von Willebrand Syndrome During the Course of Myelofibrosis: Analysis of 32 Cases.

A. Mital,W. Prejzner,A. Hellmann

DOI: https://doi.org/10.17219/acem/52361

2015-11-01

Advances in Clinical and Experimental Medicine

Abstract:BACKGROUND Identification of patients with myelofibrosis being at increased risk of acquired von Willebrand syndrome (avWS) would likely facilitate individualization of treatment and improve its outcomes. OBJECTIVES To determine the prevalence of avWS in patients with myelofibrosis, and to verify if individuals with and without this bleeding disorder differ in terms of their baseline clinical parameters. MATERIAL AND METHODS The study included 32 consecutive patients with myelofibrosis. avWS was diagnosed on the basis of abnormally low levels of von Willebrand factor and other routine tests. Patients with and without concomitant avWS were compared in terms of their demographic characteristics, present and past medical histories and laboratory parameters. RESULTS Concomitant avWS was found in 5 patients (15.6%). In 1/5 patients with avWS and in 8/27 persons without this bleeding disorder, myelofibrosis developed secondarily to polycythemia vera (n = 7) or essential thrombocytopenia (n = 2). As many as 4/5 individuals with avWS presented with clinical evidence of a bleeding disorder. The subjects with avWS differed from the remaining patients with myelofibrosis in terms of significantly lower activity of von Willebrand factor (vWF) and lower vWF to vWF antigen ratio. CONCLUSIONS All patients with myelofibrosis should be routinely evaluated for avWS with the panel of specific tests. Further, avWS should be the primary suspicion in each patient with myelofibrosis in whom clinical evidence of a bleeding disorder has emerged.
Pharmacist-social worker interprofessional relations and education in mental health: a scoping review

Paul Boylan,Jamie Knisley,Brandt Wiskur,Jessica Nguyen,Kristine Lam,Jisoo Hong,Joshua Caballero

DOI: https://doi.org/10.7717/peerj.16977

IF: 3.061

2024-02-23

PeerJ

Abstract:Background One in eight patients is affected by a mental health condition, and interprofessional mental health teams collaborate to improve patient care. While pharmacists and social workers are recognized as mental health team members, there is a lack of literature describing interprofessional relations and education between these professions, especially as it pertains to mental health. The purpose of this review was to identify and characterize reports describing pharmacist-social worker interprofessional relations and education within mental health. Methodology To address this knowledge gap, this scoping review was conducted to collect and characterize reports published between January 1, 1960 and August 18, 2023 describing pharmacist-social worker interprofessional relations and education within the field of mental health. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines were followed. Ovid MEDLINE, CINAHL, and Social Work Abstracts were searched using keywords “pharmacy student,” “pharmacist,” “social work student,” “social worker,” and “social work.” Reports were included if they were published in English and interprofessional relations or education occurred directly between (student) pharmacists and social workers. Results Three hundred twenty records were identified and three records were included: one cross sectional study, one qualitative educational project, and one case report. Each record suggested positive patient and/or educational outcomes developing from pharmacist-social worker interprofessional relations and education. In clinical practice, pharmacist-social work teams identified mental health risk factors, reduced 30-day readmissions, and improved post-discharge telehealth care. In the classroom, a social worker improved pharmacy students’ confidence assessing patient suicidal ideations. Conclusions This scoping review identified needs and areas for future research: pharmacist interprofessional education with Master of Social Work and Doctor of Social Work degree students, transitional care and mental health outcome measure reporting using evidence-based outcomes, and development of scholarly teaching projects utilizing higher-level educational frameworks beyond learner reactions.

multidisciplinary sciences
Multidisciplinary perspectives on roles of hospital pharmacists in tertiary settings: a qualitative study

Kyung Min Kirsten Lee,Ivanka Koeper,Michaela E Johnson,Amy Page,Debra Rowett,Jacinta Johnson

DOI: https://doi.org/10.1093/intqhc/mzad110

2023-12-29

International Journal for Quality in Health Care

Abstract:Abstract Backgrounds In today’s complex healthcare landscape, exacerbated by resource constraints at various levels, optimisation of health professionals’ roles is becoming increasingly paramount. Interprofessional collaboration, underpinned by role recognition and teamwork, leads to improved patient and organisational outcomes. Hospital pharmacists play a pivotal role in multidisciplinary teams, and it is imperative to understand multidisciplinary viewpoints on hospital pharmacists’ roles to guide role prioritisation and organisational efficiency. However, no study extensively investigated multidisciplinary views on values of diverse pharmacist roles in tertiary settings. This study aims to address this gap by examining non-pharmacist health professionals’ views on hospital pharmacists’ roles, recognising their specialised niches as a crucial step towards optimising their roles and services in Australia and internationally. Methods Multiple focus group discussions and interviews were held via a virtual conferencing platform. Study participants were recruited using the study investigators’ professional networks who were non-pharmacist health professionals with experience working with pharmacists in hospital settings. Data was collected from transcripts of the focus group recordings, which were later summarised using descriptive statistics and thematic analysis. Overarching themes were categorised and mapped against work system models to conceptualise organisational implications of multidisciplinary feedback, linking them to patient and organisational outcomes. Results 27 health professionals participated across focus groups and interviews, with the majority of professions being doctors and nurses. Three major themes were identified as follows: (1) overarching perceptions regarding hospital pharmacists; (2) professional niches of hospital pharmacists and (3) future opportunities to optimise hospital pharmacy services. Valued professional niches included patient and health professional educators, transitions-of-care facilitators and quality use of medicines analysts. Conclusion The study highlights critical insights into hospital pharmacists’ roles in Australia, identifying their niche expertise as vital to healthcare efficiency and success. Based on multidisciplinary feedback, the study advocates for strategic role optimisation and targeted research for enhanced clinical, economic and organisational outcomes.

health care sciences & services,health policy & services
Incorporation of a specialist mental health clinical pharmacist within a primary care network: patient referrals, prescribing decisions, and clinical outcomes

Rebecca Henry,David S Baldwin

DOI: https://doi.org/10.1177/20451253241247368

2024-09-21

Abstract:Background: The benefit of generalist pharmacists working within primary care networks (PCNs) and with general practitioners (GPs) is established. We wished to evaluate the contributions and potential benefits of a specialist mental health care prescribing pharmacist within PCNs. Method: We prospectively collected data, on clinical and demographic characteristics, referral sources, interventions, outcomes (objective and subjective), and patient feedback, from 466 completed patients, in one PCN by one specialist mental health pharmacist (working 0.5 whole time equivalent), over 15 months. Results: Referrals originated from multiple sources, including GPs, other members of the PCN mental health team, and community mental health teams (CMHTs). Two-thirds of treated patients were female; the most frequent age band was 18-30 years; the most common diagnosis was mixed depression and anxiety. Patients with diagnoses of mixed anxiety with depression or personality disorder needed more appointments than those with anxiety or depression. A range of evidence-based treatments were prescribed, including non-formulary medicines, and those medicines are more typically initiated or recommended in secondary care settings. The most frequently started medications were antidepressants (principally fluoxetine and duloxetine), followed by antipsychotics (principally quetiapine and aripiprazole): the most common dosage increases were for sertraline and quetiapine. Common non-medication recommendations were for cognitive behavioral therapy, cognitive behavioral therapy for insomnia, and other psychological therapies. Patient feedback was generally positive. Discussion: Developing and implementing a service incorporating a specialist mental health pharmacist within a PCN mental health team is potentially valuable in improving patient care quality, reducing workload for GPs and CMHTs, and enabling faster access to secondary care initiated and recommended medications. This innovative service addressed several national targets, including prevention, early intervention, and access to quality compassionate care.
Pathophysiology of Intermittent Claudication in Peripheral Artery Disease.

N. Hamburg,M. Creager

DOI: https://doi.org/10.1253/circj.CJ-16-1286

2017-02-24

Circulation Journal

Abstract:Peripheral artery disease (PAD) affects more than 200 million adults worldwide. Patients with lower extremity PAD have a heightened risk for cardiovascular events because of the systemic nature of atherosclerosis, and benefit from treatment with risk factor-modifying therapies. Limb symptoms in PAD include intermittent claudication and diminished walking ability. Arterial obstruction from atherosclerotic lesions initiates limb ischemia; however, decreased perfusion incompletely determines the clinical expression of PAD and its response to therapy. Potential mechanistic drivers of claudication in addition to arterial obstruction include inflammation, vascular dysfunction, reduced microvascular flow, impaired angiogenesis, and altered skeletal muscle function. An improved understanding of the pathophysiology of limb symptoms has the potential to accelerate development of novel therapeutic strategies to increase functional capacity in patients with PAD.
A theory-informed approach to mental health care capacity building for pharmacists

Andrea L Murphy,David M Gardner,Stan P Kutcher,Ruth Martin-Misener

DOI: https://doi.org/10.1186/1752-4458-8-46

2014-11-21

International Journal of Mental Health Systems

Abstract:BackgroundPharmacists are knowledgeable, accessible health care professionals who can provide services that improve outcomes in mental health care. Various challenges and opportunities can exist in pharmacy practice to hinder or support pharmacists’ efforts. We used a theory-informed approach to development and implementation of a capacity-building program to enhance pharmacists’ roles in mental health care.MethodsTheories and frameworks including the Consolidated Framework for Implementation Research, the Theoretical Domains Framework, and the Behaviour Change Wheel were used to inform the conceptualization, development, and implementation of a capacity-building program to enhance pharmacists’ roles in mental health care.ResultsThe More Than Meds program was developed and implemented through an iterative process. The main program components included: an education and training day; use of a train-the-trainer approach from partnerships with pharmacists and people with lived experience of mental illness; development of a community of practice through email communications, a website, and a newsletter; and use of educational outreach delivered by pharmacists. Theories and frameworks used throughout the program’s development and implementation facilitated a means to conceptualize the component parts of the program as well as its overall presence as a whole from inception through evolution in implementation. Using theoretical foundations for the program enabled critical consideration and understanding of issues related to trialability and adaptability of the program.ConclusionsTheory was essential to the underlying development and implementation of a capacity-building program for enhancing services by pharmacists for people with lived experience of mental illness. Lessons learned from the development and implementation of this program are informing current research and evolution of the program.

psychiatry
To explore clinical pharmacists’ opinions, and their perceived barriers and facilitators, to supporting clinical research delivery in secondary care

Y Jiao,J Shenton

DOI: https://doi.org/10.1093/ijpp/riad074.032

2023-11-30

International Journal of Pharmacy Practice

Abstract:Abstract Introduction The National Health Service (NHS) is confronted with significant challenges in facilitating clinical research delivery.1 Clinical pharmacists were instrumental in ensuring patient safety while conducting urgent public health studies, such as the RECOVERY trial, during the COVID-19 pandemic.2 Numerous studies have reported the positive impact of pharmacy workforce in supporting clinical research delivery3. However, it remains unclear whether pharmacists are willing to take on this extra responsibility. Aim To explore the opinions of UK clinical pharmacists towards facilitating the delivery of clinical research in secondary care. Objectives include understanding the level of knowledge of clinical research among clinical pharmacists; assessing levels of interest among clinical pharmacists towards supporting clinical research delivery; identifying clinical pharmacists’ perceived barriers and facilitators to supporting clinical research delivery; and developing recommendations to facilitate pharmacists’ engagement in research delivery. Methods This study employed a qualitative research approach and utilised convenience sampling based on the researcher’s professional network. Eight pharmacists from two secondary care NHS Trusts participated. Individual semi-structured interviews were conducted using questions adapted from the Research Capacity and Culture (RCC) tool which was validated by two clinical trial pharmacists. Keele University Research Ethics Committee provided a favourable ethical opinion. Interview transcripts were analysed to identify emerging themes by using framework analysis. Results The findings revealed that participants possessed limited knowledge of clinical research in general. The key themes identified were categorised into three domains: individual, professional, and organisational, which corresponded with the RCC tool. In the individual domain, pharmacists demonstrated interest in clinical research delivery but lacked confidence. They acknowledged clinical research as contributing to evidence-based practice and enhancing professional development. However, they expressed concerns about patient harm resulting from trial interventions and poorly designed studies generating misleading data. Within the professional domain, pharmacists' capability to support clinical research delivery was limited by inadequate training in clinical research, their clinical skills, and their disease knowledge. They perceived internal and external barriers to participation. It has been suggested to improve the research culture within the profession and promote the role pharmacists can play in delivering research among other healthcare professionals. In the organisational domain, the workplace environment was perceived to present obstacles due to competing priorities and clinical research not being seen to be a core duty by managers. Additionally, awareness of clinical research opportunities was limited and exposure to clinical research-related activities within the workplace was minimal. Discussion/Conclusion Recommendations to address these barriers include promoting clinical research training, developing mentorship programs, creating platforms to connect clinical pharmacists with research opportunities, and identifying roles that allow pharmacists to incorporate clinical research into their routine practice. This research project has several limitations, including the use of a convenience sampling method, a small sample size and potential interviewer bias due to research participants all being known to the researcher. In summary, the pharmacy workforce possesses the potential to support the challenges in clinical research delivery faced by the NHS. However, addressing the perceived barriers is critical to enhancing pharmacist involvement in this field. References 1. The Future of Clinical Research Delivery: 2022 to 2025 Implementation Plan [Internet]. UK Government; 2022 [cited 26 May 2023]. Available from: https://www.gov.uk/government/publications/the-future-of-uk-clinical-research-delivery-2022-to-2025-implementation-plan/the-future-of-clinical-research-delivery-2022-to-2025-implementation-plan 2. Kathryn Murray, pharmacist [Internet]. University of Oxford; 2022 [cited 26 May 2023]. Available from: https://www.recoverytrial.net/case_studies/kathryn-murray-pharmacist 3. Martinez J, Laswell E, Cailor S, Ballentine J. Frequency and impact of pharmacist interventions in clinical trial patients with diabetes. Clinical Therapeutics. 2017;39(4):714–22. doi:10.1016/j.clinthera.2017.02.006

English Else
Pharmacist Roles in the Medication Use Process: Qualitative Analysis of Stakeholder Perceptions

Eunhee Kim,Marcia M Worley,Samantha Yum,Anandi V Law

DOI: https://doi.org/10.1016/j.japh.2024.102186

2024-07-11

Abstract:Background: Pharmacist roles in the Medication Use Process (MUP) have advanced along with new healthcare delivery models and interprofessional collaborative practice. It is unclear whether stakeholder perceptions of pharmacist roles have evolved simultaneously. Objectives: Examine patient, pharmacist, and physician perceptions of pharmacist roles in the MUP. Methods: This IRB-approved study used a cross-sectional design with Qualtrics panels of patients, pharmacists, and physicians. Role Theory was used as a framework to develop 12-item surveys to study pharmacist role perceptions in the MUP: prescribing, transcribing, dispensing, administration, and monitoring. Content analysis was performed on the responses to open-ended questions. Results: From 1004 patients, a total of 7,217 comments were obtained on 9 questions (740-1004 comments), resulting in an average of 802 comments per question or 0.8 comments per question per respondent (CQR). Similarly, 1,620 comments from 205 pharmacists on 11 questions (121-205 comments) averaged 0.72 CQR; and 1,561 comments from 200 physicians on 11 questions (136-200 comments) equated to 0.74 CQR. Content analysis revealed recurring themes across the stakeholders: 'pharmacists', 'physicians', 'insurance', 'technology', 'collaboration', 'time', 'communication', and 'patient's responsibility'. Some role congruence was seen regarding pharmacist roles by all 3 stakeholders; noting pharmacist roles in improving all steps of the MUP, except transcribing. Pharmacists highlighted professional challenges such as staffing issues, burnout, and competing demands; which were not acknowledged by patients and physicians indicating the need to increase awareness. Conclusion: This study showed increased visibility and awareness of pharmacist roles in the MUP by all stakeholders, compared to previous research showing pharmacist roles limited to dispensing. Known barriers to pharmacy practice such as lack of provider status and reimbursement were not reported by any of the stakeholders in this study. There is a need to continuously inform stakeholders about pharmacists' expanding roles in the MUP through advocacy and marketing.
The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review

Dolly Sud,Eileen Laughton,Robyn McAskill,Eleanor Bradley,Ian Maidment

DOI: https://doi.org/10.1186/s13643-021-01586-9

2021-03-31

Systematic Reviews

Abstract:Abstract Background Individuals with severe mental illness, e.g. schizophrenia have up to a 20% shortened life expectancy compared to the general population. Cardiovascular disease, due to cardiometabolic risk and metabolic syndrome, accounts for most of this excess mortality. A scoping search revealed that there has not been a review of published studies on the role of pharmacy in relation to cardiometabolic risk, metabolic syndrome and related diseases (e.g. type 2 diabetes) in individuals with severe mental illness. Methods A mixed-methods systematic review was performed. Eleven databases were searched using a comprehensive search strategy to identify English-language studies where pharmacy was involved in an intervention for cardiometabolic risk, metabolic syndrome or related diseases in severe mental illness in any study setting from any country of origin. First, a mapping review was conducted. Then, implementation strategies used to implement the study intervention were classified using the Cochrane Effective Practice and Organisation of Care Taxonomy. Impact of the study intervention on the process (e.g. rate of diagnosis of metabolic syndrome) and clinical (e.g. diabetic control) outcomes were analysed where possible (statistical tests of significance obtained for quantitative outcome parameters reported). Quality assessment was undertaken using a modified Mixed Methods Appraisal Tool. Results A total of 33 studies were identified. Studies were heterogeneous for all characteristics. A total of 20 studies reported quantitative outcome data that allowed for detailed analysis of the impact of the study intervention. The relationship between the total number of implementation strategies used and impact on outcomes measured is unclear. Inclusion of face-to-face interaction in implementation of interventions appears to be important in having a statistically significantly positive impact on measured outcomes even when used on its own. Few studies included pharmacy staff in community or general practitioner practices ( n = 2), clinical outcomes, follow up of individuals after implementation of interventions ( n = 3). No studies included synthesis of qualitative data. Conclusions Our findings indicate that implementation strategies involving face-to-face interaction of pharmacists with other members of the multidisciplinary team can improve process outcomes when used as the sole strategy. Further work is needed on clinical outcomes (e.g. cardiovascular risk reduction), role of community pharmacy and qualitative studies. Systematic review registration PROSPERO CRD42018086411

medicine, general & internal
Potential for pharmacist prescribing in primary care: A Dutch citizen perspective

Thomas G H Kempen,Liset van Dijk,Annemieke Floor-Schreudering,Aradhana Kohli,Henk-Frans Kwint,Laura Schackmann,Lilian H D van Tuyl,Mette Heringa

DOI: https://doi.org/10.1016/j.rcsop.2024.100453

2024-05-23

Abstract:Background: Medication prescribing by pharmacists is a task shifting approach to help ensure quality and accessibility of healthcare. In many countries, like the Netherlands, pharmacist prescribing is not legally ensured, and it is unknown what citizens think of its potential introduction. Objective: To investigate citizen perspectives on the potential role of pharmacists in prescribing in primary care. Methods: A Citizen Platform with citizens (>18 years) from the Netherlands was conducted in October 2022. This consisted of a one-day program in which the participants were engaged in interactive assignments and received expert presentations to foster the development of informed opinions. In the final assignment, 3 participant groups designed their ideal future scenario including preconditions regarding the role of the pharmacist in prescribing in primary care. All assignments were recorded, and notes were taken. The researchers then consolidated the 3 scenarios into one version and categorized the preconditions. The Citizen Platform results were summarized and subsequently discussed in 2 online focus groups with other citizens in February 2023 to investigate the perspectives of less informed citizens. Focus group discussions were audio-recorded, transcribed, and thematically analyzed. Results: The Citizen Platform (n = 10) resulted in a shared scenario involving a primary care center where general practitioners (GPs) pharmacists and other healthcare professionals collaborate as a team. In this scenario, pharmacists can modify treatment in certain chronic diseases, manage minor ailments and support GPs with the care for patients with complex needs. Preconditions needed to realize this scenario include having shared medical records, the GP retaining the overview of the care for the patient and additional training for pharmacists. The focus groups (n = 6, in total) yielded 5 themes which acknowledge potential pharmacist prescribing but depict a more skeptical view towards pharmacist prescribing and include several concerns, for example pharmacists' potential conflict of interest. Conclusions: Citizens that are informed about opportunities for pharmacy prescribing are capable of sketching potential scenarios for pharmacist prescribing in a collaborative primary care context. Less informed citizens seem more skeptical towards pharmacist prescribing.
Health-related stakeholders’ perceptions of clinical pharmacy services in Qatar

Tesnime Jebara,Scott Cunningham,Katie MacLure,Ahmed Awaisu,Abdulrouf Pallivalapila,Moza Al Hail,Derek Stewart

DOI: https://doi.org/10.1007/s11096-020-01114-0

IF: 2.305

2020-09-22

International Journal of Clinical Pharmacy

Abstract:Abstract Background In Qatar, the National Vision 2030 and the National Health Strategy 2018–2022 articulate the need to improve healthcare delivery by better utilisation of the skilled workforce. In this regard, pharmacy practice is rapidly advancing and several extended pharmacy services are now available in institutionalised settings. Objective This study aimed to determine health-related stakeholders’ perceptions of current clinical pharmacy services in Qatar, and the potential development and implementation of further patient-centred roles. Setting All major organisations and institutions relating to the practice, education, regulation, and governance of pharmacy in Qatar. Method Qualitative, face-to-face semi-structured interviews were conducted with individuals in key strategic positions of policy development and influence (i.e. health-related academic leaders, healthcare policy developers, directors of medicine/pharmacy/nursing, and patient safety leaders). Participants were recruited via a combination of purposeful and snowball sampling, until the point of data saturation was reached. The interview guide was grounded in the Consolidated Framework for Implementation Research domains of innovation characteristics, outer and inner setting, characteristics of individuals, and implementation process. The interviews were digitally recorded, transcribed and independently analysed by two researchers using the Framework approach. Main outcome measure Perceptions of stakeholders regarding current and potential for future clinical pharmacy services in Qatar. Results Thirty-seven interviews were conducted with stakeholders of policy influence in healthcare. The interviewees reported a variety of clinical pharmacy services available in Qatar, which they perceived as positively impacting patient care outcomes, pharmacists’ professional autonomy, and the healthcare system in general (innovation characteristics). However, they perceived that these services were mainly performed in hospitals and less in community pharmacy setting (inner setting) and were undervalued by patients and the public (outer setting). Expansion of pharmacists’ clinical activities was supported, with recognition of facilitators such as the skillset and training of pharmacists, potential time release due to automation and well-considered implementation processes (characteristics of individuals, inner setting, process). Conclusion Health-related stakeholders in Qatar have positive perceptions of current clinical pharmacy services and support the expansion of pharmacist’s roles. However, service development needs to consider the issues of patient and public awareness and initially target institutionalised healthcare settings.

pharmacology & pharmacy

Use of microcirculatory parameters to evaluate chronic venous insufficiency.

New roles for pharmacists in community mental health care: a narrative review

Community pharmacists’ views and experiences of delivering in-pharmacy medication reviews for people living with severe and persistent mental illness: a qualitative study

Accelerating analysis for metabolomics, drugs and their metabolites in biological samples using multidimensional gas chromatography.

A roadmap beyond dispensing for educating and training community pharmacists on key mental health competencies: A mixed-methods national study

Intrinsic optical transistor action in homeotropically aligned nematic crystal films.

AntimicrobiALs Peptidoglycan hydrolase enzyme fusions for treating multi-drug resistant pathogens

Exploring Youth-Perceived Barriers and Attitudes Towards the Clinical Use of Pharmacogenetic Testing to Optimise Antidepressant Pharmacotherapy

Mental Health Simulation Training for Pharmacy workforce in Secondary Care

Exploring Australian pharmacists' views toward reducing the risk of medicines-related harm in aged care residents

Acquired von Willebrand Syndrome During the Course of Myelofibrosis: Analysis of 32 Cases.

Pharmacist-social worker interprofessional relations and education in mental health: a scoping review

Multidisciplinary perspectives on roles of hospital pharmacists in tertiary settings: a qualitative study

Incorporation of a specialist mental health clinical pharmacist within a primary care network: patient referrals, prescribing decisions, and clinical outcomes

Pathophysiology of Intermittent Claudication in Peripheral Artery Disease.

A theory-informed approach to mental health care capacity building for pharmacists

To explore clinical pharmacists’ opinions, and their perceived barriers and facilitators, to supporting clinical research delivery in secondary care

Pharmacist Roles in the Medication Use Process: Qualitative Analysis of Stakeholder Perceptions

The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review

Potential for pharmacist prescribing in primary care: A Dutch citizen perspective

Health-related stakeholders’ perceptions of clinical pharmacy services in Qatar